A cohort study of a tailored web intervention for preconception care by Eleonora Agricola et al.
Agricola et al. BMC Medical Informatics and Decision Making 2014, 14:33
http://www.biomedcentral.com/1472-6947/14/33RESEARCH ARTICLE Open AccessA cohort study of a tailored web intervention for
preconception care
Eleonora Agricola1*, Elisabetta Pandolfi1, Michaela V Gonfiantini1, Francesco Gesualdo1, Mariateresa Romano2,
Emanuela Carloni1, Pierpaolo Mastroiacovo3 and Alberto E Tozzi1Abstract
Background: Preconception care may be an efficacious tool to reduce risk factors for adverse pregnancy outcomes
that are associated with lifestyles and health status before pregnancy. We conducted a web-based cohort study in
Italian women planning a pregnancy to assess whether a tailored web intervention may change knowledge and
behaviours associated with risks for adverse pregnancy outcomes.
Methods: The study was entirely conducted on the web on a cohort of Italian women of childbearing age. Data
collected at baseline on health status, lifestyles and knowledge of risk factors for adverse pregnancy outcomes were
used for generating a tailored document including recommendations for folic acid supplementation, obesity and
underweight, smoking, alcohol consumption, vaccinations, chronic and genetic diseases, exposure to medications.
Prevalence of risk factors and knowledge was assessed 6 months after the intervention. Logistic regression models
were used to explore the factors associated with risk factors after the intervention.
Results: Of the 508 enrolled women, 282 (55.5%) completed the study after 6 months since the delivery of tailored
recommendations. At baseline, 48% of the participants took folic acid supplementation (95% CI 43.2; 51.9) and 69%
consumed alcohol (95% CI 64.7; 72.9). At the follow up 71% of the participants had a preconception visit with a
physician. Moreover we observed a decrease of alcohol consumption (−46.5% 95% CI −53.28; −38.75) and of the
proportion of women not taking folic acid supplementation (−23.4% 95% CI −31.0; 15.36). We observed an
improvement in knowledge of the information about the preconception behaviours to prevent adverse pregnancy
outcomes (20.9% 95% CI 14.6%; 27.1%). Having a preconception visit during follow up was significally associated to
an increase in folic acid supplementation (OR 2.53 95% CI 1.40; 4.60).
Conclusions: Our results suggest that a tailored web intervention may improve general preconception health in
women planning a pregnancy. A web preconception intervention may be integrated with classic preconception
care by health professionals. Clinical trials should be conducted to confirm these findings.
Keywords: Preconception care, Preconception health, Preconception counselling, Adverse pregnancy outcomes,
Folic acid, Web intervention, Internet, LifestylesBackground
Maternal lifestyle and health status are associated with
the risk of adverse pregnancy outcomes (APOs) [1-7].
Preconception care can effectively inform women on
how to identify and reduce risk factors for APOs through
appropriate prevention [8]. Specifically, preconception
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unless otherwise stated.achievement of a proper weight, folic acid supplementation,
review and update of vaccinations, appropriate manage-
ment and therapy of chronic diseases. In fact, some of these
interventions have been shown to have effects on maternal
health status, while the effectiveness in reducing the inci-
dence of APOs still needs substantial evidence [9].
The Internet has achieved a pivotal role as a source of
health information for physicians and for the general
public [10,11], and may be an effective tool for delivering
health care interventions to patients. A large number of
web interventions aimed at improving lifestyles (smoking,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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conducted, showing various levels of efficacy [12].
Web interventions offer several advantages as compared
to traditional interventions because of high penetration
of the Internet in the general population, wide enrol-
ment potential through social media, interaction and
personalization, time and costs savings, anonymity and
privacy maintenance [13]. Although women widely use
the Internet to get information on fertility and pregnancy
[14], preconception counselling or interventions to reduce
risk factors for APOs have rarely been delivered through
the web [15,16].
We conducted a cohort study to explore the efficacy of
an informative and tailored intervention in a population of
Italian women of childbearing age planning a pregnancy.
To this aim, we assessed their knowledge and prevalence
of risk factors for APOs at baseline, and six months after




We conducted a cohort study in Italian women of child-
bearing age who were planning a pregnancy within a year.
Women were recruited on a web platform where they
were profiled through a questionnaire on knowledge
and behaviours. A summary of the study is provided
(Additional file 1). Participants were then provided a
downloadable document including recommendations for
preventing risk factors for APOs based on their profile. A
fictitious example of a tailored document is provided
(Additional file 2). Details of the questionnaires and of the
recommendations included in the tailored document are
discussed in the following sections.
Prevalence of risk factors and knowledge was assessed
again 6 months after the intervention. The study was
approved by the Bambino Gesù Children’s Hospital
ethical committee.
Population, promotion of the study and enrolment
The study was conducted from September 2011 to May
2013. A convenience sample was included in the study
through inclusion of women consecutively visiting the
platform and requesting to be enrolled. Eligibility and
exclusion criteria were reviewed through a questionnaire
on the study web platform. Eligibility criteria included: 1)
female gender; 2) age 18–45 years; 3) residence in Italy; 4)
Italian language spoken; 5) plan of getting pregnant within
the following year; 6) active email address and internet
access; 7) online informed consent. Women with an on-
going pregnancy were excluded from the study. Women
not satisfying eligibility criteria were recommended to visit
a web site on risk factors prevention during preconception
period and pregnancy. The study was entirely conductedon the web and participants were never interviewed in
person.
The study was promoted through Facebook and through
articles explaining the project. The articles were freely
published on 10 web sites dedicated to women’s health
and family care. Facebook posts promoting the study were
published twice a week for 2 months. Enrolment contin-
ued from September 2011 to November 2012, while the
remaining six months, until May 2013, were dedicated to
follow-up only. No paid advertisement was ever used and
no incentives were offered for participation in the study.
Web platform and intervention
Women meeting inclusion criteria were provided unique
credentials (unique identifier, user name, and password)
to access their personal account. Multiple enrolments by
the same participant were prevented through manual
review of multiple records with identical email address,
IP address and responses to questionnaires.
Upon enrolment, women were asked to fill in a ques-
tionnaire on social and demographic data, personal and
family medical history, lifestyles and knowledge of risk
factors for APOs. The investigated risk factors included:
obesity and underweight, smoking, alcohol consumption,
genetic diseases and malformation, underlying diseases,
exposure to medications, need for vaccination against
rubella, varicella and hepatitis B. Folic acid supplementa-
tion was also investigated. Based on the information on
the participant’s risk factors, a tailored set of recommen-
dations was provided through a downloadable document
created through an algorithm embedded in the website.
The recommendation set was prepared following the
guidelines provided by the American College of Obste-
tricians and Gynecologists (ACOG) [17]. The tailored
document included a summary of personal information
and a number of recommendations profiled on the partici-
pant’s risk factors. Each recommendation included no more
than 2 text pages and included: a) general information on
condition or exposure; b) type and frequency of associated
adverse events concerning pregnancy; c) recommendations
either on strategies to change behaviour or on medical
interventions. Finally, the participants were invited to
have a preconception visit with a health professional
(her general practitioner, her obstetrician/gynaecologist)
in order to have a complete assessment and counselling
before getting pregnant. Participants were also invited to
show the tailored document to the physician during the
preconception visit (Additional file 2).
Follow-up
Participants were reminded of the recommendation docu-
ment through a monthly email. Six months after the
enrolment, participants were invited by email to fill in a
questionnaire including the same information on know-
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Figure 1 Flowchart of participants to the pilot study.
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naire also investigated if the participant had a preconcep-
tion visit after enrolment before getting pregnant. Enrolled
women could withdraw from the study at any moment.
Definitions and statistical analysis
Incomplete and inconsistent questionnaires were excluded
from the analysis.
We described the population of participants through
their socio-demographic, clinical, and behavioural char-
acteristics. Consanguinity was defined as union between
people that are related as first cousin or closer. Family
history included genetic diseases, birth defects and
malformations up to the first cousin relationship. Under-
lying diseases included type 1 diabetes, hypertensions, epi-
lepsy, hypo- and hyperthyroidisms, hyperphenylalaninemia
and asthma. Regarding drugs consumption, we asked for
any current therapy, including over-the-counter medica-
tions. Drinking alcohol and smoking were defined as drink-
ing any quantity of alcohol and smoking any quantity of
cigarettes. An obstetrician/gynaecologist visit was defined
as a routine check-up visit with an obstetrician or a gynae-
cologist, not necessarily including preconception counsel-
ling. We defined a woman as needing a rubella or hepatitis
B vaccination if she had a) a negative serological test or no
test ever performed and b) no specific immunization re-
ceived. Need of varicella vaccination was defined as a) a
negative serological test or no test ever performed and b)
no specific immunization received and c) no recall of clin-
ical disease. At follow up, preconception visit was defined
as a visit with a health professional (her general practitioner,
her obstetrician/gynaecologist) in order to have a complete
assessment and counselling before getting pregnant.
We calculated the difference (percentage and 95% CI)
between the prevalence of risk factors, and the level of
knowledge of risk factors for APOs, before and six months
after the delivery of tailored recommendations.
We studied the proportion of participant not taking folic
acid supplementation and the prevalence of the following
risk factors at enrolment: no visit with an obstetrician/
gynaecologist in the last year, alcohol consumption,
smoking, being underweight (BMI <18.5) or overweight
(BMI ≥25), the need for vaccination against varicella,
rubella, and hepatitis B.
We also studied the knowledge of the following items:
folic acid supplementation, timing of preconception
counselling, inheritability of malformations and genetic
diseases, age at risk for Down syndrome, importance of
maintaining a normal weight to prevent adverse pregnancy
outcomes, need of testing susceptibility to infectious dis-
eases before pregnancy, risk of vaccine preventable diseases
which are harmful during pregnancy, underlying maternal
diseases, smoking, medications and drinking alcohol on
pregnancy outcomes.Differences in proportions were assessed through the
Chi square or Fisher exact test as appropriate. Differ-
ences in continuous variables were assessed through the
Student t test.
Moreover, through logistic regression, we explored the
effect of the following variables on risk factor prevalence
after the intervention: parity, obstetrician or gynaecologist
visit in the past 12 months, Pap smear test performed
in the last 5 years; having initiated a pregnancy before
the end of follow up; having had a preconception visit
before the follow up questionnaire. We performed multiple
logistic regression models in which current pregnancy
was included as a single independent variable or as an
interaction term with the other variables. We also adjusted
the analysis for the following variables: age, geographical
area of residence, education, employment, obstetrician or
gynaecologist visit before enrolment, any previous miscar-
riage, family history of malformations, chronic or genetic
diseases, underlying disease, current continuous use of
any medication.
We used the STATA statistical package to perform the
statistical analysis; 95% confidence intervals have been
calculated according to Newcombe [18].
Results
From September 2011 to November 2012, 896 women
applied to participate in the study. 508 (56.7%) of them
satisfied eligibility criteria and provided complete infor-
mation at enrolment; 282 (55.5%) of them completed the
follow-up (Figure 1).
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and prevalence of baseline risk factors among participants
who completed the follow up and in those who did not.
The majority of participants reported to be graduated,
employed and planning their first pregnancy. Most partici-
pants had been visited by an obstetrician/gynaecologist in
the past year and had undergone a Pap smear test in the
past 5 years. Nearly 10% reported previous miscarriages
and 12.5% had a family history of malformations, disabil-
ities, genetic diseases or chronic diseases.
More than a half of participants were not taking folic
acid supplementation; nearly 70% reported to drink alco-
hol, while smoking was less prevalent (16.9%); one fifth
was overweight; nearly 15% reported to have an under-
lying disease. One fifth reported to take medicines. Re-
garding immunization against preventable infectious
diseases, 21.2%, 13.3%, and 43.7% needed a vaccination
against rubella, varicella and hepatitis B respectively.
Women who did not complete the follow-up were less
frequently graduated and employed, were more frequently
overweight and more frequently reported previous miscar-
riages and smoking. Moreover, they had performed a PapTable 1 Characteristics of participants and prevalence of risk
Participants w
the survey (n =
Age, yrs (SD) 32.4 (4.6)
University degree, N (%) 184 (65.2)
Employed, N (%) 251 (89.0)
Residence
North, N (%) 125 (44.3)
Center, N (%) 114 (40.4)
South, N (%) 43 (15.2)
Planning first pregnancy, N (%) 213 (75.5)
Previous miscarriage, N (%) 16 (5.7)
Obstetrician/Gynaecologist visit in the last year, N (%) 243 (86.2)
Pap-test in the last 5 years N (%) 265 (94.0)
Family history of malformation, N (%) 31 (11.0)
Consanguinity, N (%) 5 (1.8)
Underlying diseases, N (%) 45 (16.0)
Current medicine consumption, N (%) 51 (18.1)
No Folic acid supplementation N (%) 148 (52.5)
BMI <18.5 N (%) 23 (8.2)
BMI ≥ 25 N (%) 52 (18.5)
Need of vaccination against rubella N (%) 55 (19.5)
Need of vaccination against varicella N (%) 37 (13.1)
Need of vaccination against hepatitis b N (%) 117 (41.5)
Smoking (any quantity) N (%) 37 (13.1)
Drinking alcohol (any quantity) N (%) 202 (71.6)
Missing values may affect denominators of different items.test less frequently compared to those who completed the
follow-up.
Table 2 shows risk factors prevalence after the inter-
vention and reports the differences between prevalence
figures at the beginning and at the end of the study. The
highest variation was observed for alcohol consumption
(−46.45%; 95% CI −53.28; −38.75), followed by folic acid
supplementation (−23.4%; 95% CI −31.0; 15.36). Suscep-
tibility to hepatitis B (−22.34%; 95% CI −29.5; −14.84)
and rubella (−13.83%; 95% CI −19.29; 8.46) also decreased
significantly. Moreover, at follow up, 200/282 (70.9%)
reported to have had a preconception visit before get-
ting pregnant and 102/282 (36.2%) reported to have
got pregnant.
Regarding participants’ knowledge of risk factors for
APOs, the overall level of knowledge was high at base-
line, with the exception of knowledge on adverse effects
of overweight and obesity, teratogenicity of some drugs,
alcohol consumption, maternal underlying diseases and
infectious diseases (Table 3). In comparison with women
who did not complete the follow up, the participant
who ended the study had a higher knowledge of APOsfactors for adverse pregnancy outcomes at baseline
ho completed
282)
Participants who did not




32.5 (5.1) 32.4 (4.8) 0.832
122 (54.0) 306 (60.2) 0.012
175 (77.4) 426 (83.9) <0.001
88 (38.9) 213 (41.9) 0.061
85 (37.6) 199 (39.2)
53 (23.5) 96 (18.9)
164 (74.2) 377 (75.0) 0.734
33 (14.9) 49 (9.7) 0.001
183 (82.8) 426 (84.7) 0.298
191 (86.4) 456 (90.7) 0.004
32 (14.16) 63 (12.5) 0.257
9 (4.1) 14 (2.8) 0.12
28 (12.8) 73 (14.6) 0.32
51 (22.9) 102 (20.2) 0.184
118 (53.4) 266 (52.9) 0.839
11 (4.9) 34 (6.7) 0.151
55 (24.9) 107 (21.3) 0.083
52 (23.4) 107 (21.2) 0.285
30 (13.5) 67 (13.3) 0.913
103 (46.6) 220 (43.7) 0.251
48 (21.7) 85 (16.9) 0.011
148 (67.0) 350 (69.6) 0.259
Table 2 Comparison of prevalence of risk factors for APOs before and after the intervention
Prevalence of risk factors for
APOs after intervention n = 282 (%)
Difference, % (95% CI) P
No folic acid supplementation 82 (29.1) −23.4 (−31.0; 15.36) <0.001
BMI < 18.5 16 (5.7) −2.48 (−6.84; −1.79) 0.25
BMI ≥ 25 61 (21.6) 3.19 (−3.43; 9.78) 0.34
Need of vaccination against rubella 16 (5.7) −13.83 (−19.29; 8.46) <0.001
Need of vaccination against varicella 16 (5.7) −7.45 (−12.38; 2.64) 0.002
Need of vaccination against hepatitis b 54 (19.1) −22.34 (−29.5; −14.84) <0.001
Smoking, any quantity 16 (5.7) −7.45 (−12.38; 2.64) 0.002
Drinking alcohol, any quantity 71 (25.2) −46.45 (−53.28; −38.75) <0.001
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the effect of vaccinations to prevent harmful infection
diseases (85.8% vs 75.7% p = 0.004) (Table 3).
At the end of the study, the participants showed a
significant increase in knowledge of correct preconcep-
tion behaviours. Correct knowledge of timing of precon-
ception counselling decreased with respect to baseline
(−7.4%; 95% CI −14.5; 0.3) (Table 4).
The multivariate analysis (Table 5) showed that women
who had a visit with an obstetrician/gynaecologist in the
last 12 months were less frequently underweight (0.20 OR;
95% CI 0.06; 0.63) and less frequently drank alcohol (0.42
OR; 95% CI 0.18; 0.99) after the intervention; women
who had a preconception visit at follow up were more
frequently taking folic acid supplementation (2.53 OR;
95% CI 1.40; 4.60) and had more frequently a high BMI
(2.18 OR; 95% CI 1.04; 4.58); women who had performed
a Pap-test in the last 5 years were less frequentlyTable 3 Knowledge of risk factors for adverse pregnancy outc
Participants giving a correct a
at baseline among those who
completed the survey n = 282
General preconception behaviours 199 (70.6)
Folic acid supplementation 270 (95.7)




Age at risk for Down syndrome 263 (93.3)
Maintaining a normal weight to
prevent adverse pregnancy outcomes
276 (97.9)
Overweight and obesity 37 (13.1)
Underlying maternal diseases 55 (19.5)
Smoking 276 (97.9)
Medications 34 (12.1)
Drinking alcohol 164 (58.2)
Need of testing susceptibility
to infectious diseases
242 (85.8)
Immunization before pregnancy 147 (52.1)overweight (0.27 OR; 95% CI 0.08; 0.95) and women who
had got pregnant during follow-up were more fre-
quently taking folic acid supplementation (3.7 OR; 95% CI
(1.96; 7.19), had more frequently a high BMI (2.25 OR; 95%
CI (1.24; 4.09), were less frequently immunized against ru-
bella (0.11 OR; 95% CI (0.01; 0.88) and less frequently
drank alcohol (0.20 OR; 95% CI (0.10; 0.42) after the
intervention.
The other factors included in the analysis did not
show a significant association with the outcomes nor
interaction terms with current pregnancy showed a sig-
nificant association.
Discussion
A single, informative, personalized web intervention may
decrease prevalence of risk factors for APOs in women
planning a pregnancy.omes at baseline
nswer
(%)
Participants giving a correct answer
at baseline among those who did




146 (67.6) 345 (69.3) 0.476
201 (93.1) 471 (94.6) 0.189
160 (74.8) 381 (76.8) 0.346
171 (79.9) 404 (81.5) 0.441
202 (94.4) 465 (93.8) 0.607
210 (98.1) 486 (98.0) 0.839
30 (14.0) 67 (13.5) 0.772
35 (16.4) 90 (18.1) 0.368
201 (93.9) 477 (96.2) 0.023
33 (49.3) 67 (13.5) 0.278
128 (59.8) 292 (58.9) 0.71
162 (75.7) 404 (81.5) 0.004
98 (45.8) 282 (56.9) 0.162
Table 4 Comparison of knowledge of risk factors for APOs before and after the intervention
Participants giving a correct answer at follow up
among those who completed the survey n = 282 (%)
Difference, % 95% CI P
General preconception behaviours 258 (91.5) 20.9 <0.001
(14.6; 27.1)
Folic acid supplementation 275 (97.5) 1.7 0.24
(−1.3; 5.1)
Timing of preconception counselling 200 (70.9) −7.4 0.04
(−14.5; 0.3)
Inheritability of malformations and genetic diseases 128 (45.4) −37.2 <0.001
(−44.2; 29.6)
Age at risk for Down syndrome 267 (94.7) 1.4 0.48
(−2.6; 5.5)
Maintaining a normal weight to prevent adverse
pregnancy outcomes
275 (97.5) −0.3 0.78
(−3.1; 2.4)
Overweight and obesity 33 (11.7) −1.4 0.61
(−6.9; 4.1)
Underlying maternal diseases 42 (14.9) −4.6 0.15
(−10.8; 1.6)
Smoking 274 (97.2) −0.7 0.59
(−3.6; 2.1)
Medications 34 (12.1) 0 1,00
Drinking alcohol 173 (61.3) 3.2 0.44
(−4.9; 11.2)
Need of testing susceptibility to infectious diseases 251 (89.0) 3.2 0.25
(−2.3; 8.7)
Immunization before pregnancy 128 (46.0) −6.74 0.11
(−14.85; 1.5)
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APOs in women of childbearing age in order to inform
public health actions and evaluate efficacy of interventions
is feasible and easy. Our results also show that preventable
risk factors for APOs are frequent in Italian women and
deserve a thorough intervention through preconception
counselling.
To our knowledge, the present intervention is the first
web-based study to deliver preconception recommenda-
tions to a wide population of women of childbearing age
planning a pregnancy. Moreover, this is one of the few
studies aimed at improving general preconception health
targeting multiple risk factors [6,7,9].
The Internet has been rarely used for preconception
care promotion. A web-based study promoted folic acid
supplementation among a selected population of women,
resulting in an improved readiness to take folic acid in
comparison with traditional educational methods [15]. A
different study conducted through the web on a cohort
of women of reproductive age investigated associationsbetween preconception lifestyle and fertility, showing an
effect of overweight and physical activity on fecundability
[19-22]. Moreover, risk factors such as smoking, alcohol
intake, obesity and physical inactivity reduce adherence
to the preconception recommendation of folic acid intake
[23]. Recently, an innovative computerized animated char-
acter has been developed and successfully used to iden-
tify and modify preconception risks in a pilot women
community [16].
When analysing behavioural changes after the inter-
vention, we observed a significant decrease in almost
all the risk factors for APOs. A remarkable result is that
71% of women who completed the follow-up had a pre-
conception visit with their physician. Actually, it may
be possible that the observed reduction of risk factors
could have been mainly driven by recommendations
provided by physicians and not only by this intervention.
Indeed, an increase in folic acid supplementation was
significantly associated with having had a preconception
visit during follow up.
Table 5 Factors associated with risk factors for adverse pregnancy outcomes
Previous pregnancies Obstetrician or gynaecologist visit
in the 12 months before enrolment
Pap smear test performed in the
last 5 years before enrolment
Pregnancy at follow up OR Preconception visit
during follow up OR
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Folic acid supplementation 1.02 1.49 1.42 3.7 2.53
(0.528; 1.97) (0.66; 3.369) (0.442; 4.56) (1.96; 7.19) (1.40; 4.60)
0.956 0.342 0.556 0.000 0.002
BMI < 18.5 1.052 0.20 2.89 0.99 0.71
(0.31; 3.55) (0.06; 0.63) (0.31; 27.04) (0.34; 2.95) (0.24; 2.12)
0.935 0.006 0.353 0.995 0.543)
BMI ≥ 25 1.34 1.81 0.27 2.25 2.18
( 0.70; 2.61) (0.63; 5.19) (0.08; 0.95) (1.24; 4.09) (1.04; 4.58)
0.388 0.271 0.04 0.008 0.039
Need vaccination against rubella 0.20 0.75 1.90 0.11 0.37
(0.02; 1.64) (0.16; 3.40) (0.17; 21.57) (0.01; 0.88) (0.13; 1.09)
0134 0.709 0.605 0.037 0.071
Need vaccination against varicella 1.66 1.80 Not given 0.33 1.10
(0.53; 5.17) (0.23; 14.37) (0.09; 1.21) (0.33; 3.649)
0.380 0.578 0.095 0.869
Need vaccination against hepatitis b 1.14 1.26 0.72 0.80 1.47
(0.54; 2.38) (0.47; 3.39) (0.20; 2.66) (0.42; 1.53) (0.71; 3.02)
0.731 0.644 0.627 0.501 0.294
Smoking 0.431 2.18 0.31 0.14 0.49
(0.09; 2.09) (0.31; 2.10) (0.04; 2.18) (0.02; 1.10) (0.16; 1.48)
0.296 0.429 0.237 0.062 0.205
Drinking alcohol 1.04 0.42 2.13 0.20 1.44
(0.52; 2.07) (0.18; 0.99) (0.58; 7.98) (0.10; 0.42) (0.73; 2.81)
0.920 0.05 0.259 0.000 0.286
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up started a pregnancy within 6 months from enrolment.
We observed that women that started a pregnancy during
follow up more frequently started folic acid supplemen-
tation, received immunization against rubella, and quit-
ted drinking alcohol. These results are in line with the
observation that the motivation to change behaviour is
stronger in women planning a pregnancy than in those
of childbearing age [9].
We measured a high prevalence of risk factors at en-
rolment. Moreover, the women who did not complete
the follow up had a higher prevalence of risk factors for
APOs than those who completed the study. Interven-
tions addressed at reducing the prevalence of multiple
risk factors require strong engagement and time from
the respondent [24]. As a matter of fact, more at-risk
women received a longer set of recommendations, and
were therefore asked a stronger effort to make a change.
This entailed a higher risk of attrition. Prevention strategies
should focus on women with higher risk profiles, and inter-
ventions should be appropriately designed for this high-risk
group in order to effectively motivate them, thus preventing
drop-outs.
Interestingly, we measured a high proportion of women
needing a vaccination for one or more preventable infec-
tious diseases that is in line with the Italian seroprevalence
[25,26]. This result must be framed into the Italian
immunization scenario. Rubella vaccine has been intro-
duced in 1972; coverage for MMR vaccine only recently
increased in children [27-29] and a special strategy for
congenital rubella elimination has been recently imple-
mented [30]. Varicella immunization is actively offered
only in a few Italian Regions and the incidence of this
disease is high in childhood. Immunization, however,
is recommended in adolescents with no history of the
disease [31]. Hepatitis B immunization is universally
offered to infants in the first year of life since 1991 and
a screening for hepatitis B is systematically performed
during pregnancy.
Beside the likelihood of being captured by existing im-
munization strategies, we might have overestimated the
proportion of women requiring a vaccination, as we in-
cluded in the definition of need for vaccine also women
who did not know their immunization status, and that
therefore could actually have been already protected. How-
ever, it is likely that the proportion of women classified as
“susceptible” according to our definition actually reflects
the proportion of women that will be likely tested or vacci-
nated by their gynaecologist while planning a pregnancy.
Regarding knowledge of APOs, at enrolment most
participants were already well informed on almost all
items included in the study. This finding is apparently
in contrast with the high prevalence of behaviours that
pose a risk for pregnancy outcomes. A discrepancy betweenlevel of knowledge and actual behaviours has previously
been reported [6,32]. After our intervention, knowledge of
participants showed a significant change for the general
information on preconception behaviours only.
Our study has a number of limitations. First of all, since
all women received the intervention we cannot state that
the changes observed are due to the intervention itself. In
order to answer to this question, a properly designed trial
would be needed.
Our web intervention was purely informative and aimed
at delivering appropriate information on the risks associ-
ated with specific behaviours and medical conditions,
as well as at promoting preconception counselling. The
pivotal characteristics of our approach were: the possibility
to fill in a questionnaire where and when the participant
was more comfortable; a tailored set of recommendations
that was immediately provided in a document which was
always available for downloading; a summary of the partic-
ipant’s clinical characteristics, included in the document
front page, easy to show up to physicians during precon-
ception counselling; a short and readable structured text
illustrating the rationale, the actions, and the expected
impacts on each woman for each recommendation; a
positive reinforce for positive behaviours; a monthly
reminder to resume the information provided at enrol-
ment. Our study design does not include a control group,
therefore we cannot draw sound conclusions on the effi-
cacy of our intervention. Nevertheless, general knowledge
on preconception behaviours increased consistently. It
is likely that the potential confounders included in the
analysis do not entirely explain the change in the risk
factor prevalence, suggesting that the intervention itself
may play a role. Nevertheless, our study shows that a
web-based preconception intervention is feasible in women
planning a pregnancy.
The validity of data collected through the web only may
be questionable. However, other authors showed that web
questionnaires are efficient means for data collection and
we did not find evident inconsistencies during review of
collected data [33].
As in other web-based interventions, one limitation is
represented by the selection of the study participants.
The study was promoted on web-sites dedicated to
women’ health and family care and through a Facebook
account. The media used for the study promotion may
have likely influenced the characteristics of the study
population. The selected population may actively and
frequently use the Internet for health information more.
According to the National Institute of Statistics, in Italy
46.5% of women of childbearing age use the internet on
this purpose [34]. Therefore the segment of population
we have selected could be more motivated regarding
participation in a preconception intervention study. The
comparison with Italian Birth Registers [35] and with the
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in our study differed from the Italian population of
women of childbearing age with respect to sociodemo-
graphic variables and lifestyles. In our sample, the mean
age was 32.6. This data is comparable to the mean age
(31.8 years) of Italian nulliparous women, according to the
Italian Institute of Statistics [37]. No significant difference
was found regarding smoking rate (16.9% vs. 16.9%) and
BMI < 18.5 (8.2% vs. 9.6%) [36,38]. On the other hand,
compared to Italian women of childbearing age, women
included in our sample had a higher education level (60.2%
vs. 20.7%), were more frequently employed (83.9% vs.
46.40%) and reported better medical conditions and lifestyle
behaviours at baseline, in particular concerning overweight
(21.3% vs. 37.0%), drug consumption (20.2% vs. 44.1%)
and prevalence of chronic diseases (14.6% vs. 42.1%) [36].
Regarding miscarriages, our population presented a rate
similar to that reported in the Italian Birth Registers (9.7%
vs. 13.4%) [35]. These sample characteristics could have
facilitated a more successful response to the intervention.
Nevertheless, although our results are not easily gene-
ralizable to the general population, our sample is likely
representative of the specific population of women plan-
ning a pregnancy that frequently use the Internet for
health purposes. Our results suggest that this specific
population may benefit from a web-based intervention
aimed at reducing preconception risk factor.
Furthermore, social engagement, active use of the Inter-
net [39] and usability of the web page [40] may affect
participation in web intervention studies.
We observed a remarkably high attrition that was, how-
ever, consistent with that reported by other studies [41].
Interestingly, unemployment, history of previous miscar-
riages and smoking positively predicted loss to follow-up.
As discussed before, this finding suggests that a higher
risk of attrition exists for women with a high-risk profile.
Strategies for limiting loss to follow-up may include
counsellor support, use of alternative means of commu-
nication as phone, updates of the intervention website,
a more easy-to-read tailored document [40,42,43].Conclusions
Our study suggests that the web may be a valid tool for
promoting preconception care. Web-based interventions
have a low cost and may therefore represent a useful com-
plement to traditional preconception counselling. More-
over, such interventions may be useful to continuously
monitor the association between risk factors, preconception
behaviours and pregnancy outcomes. A formal clinical trial
with active engagement of participants and frequent recalls
to prevent attrition will be useful to better address the effect
of a web intervention to inform and implement prevention
campaigns and health professionals’ activities. This studyinforms clinical trial studies regarding potential confound-
ing variables to be included in the design.
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